Status:
COMPLETED
Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of Scabies
Lead Sponsor:
Combined Military Hospital Abbottabad
Conditions:
Scabies
Eligibility:
All Genders
3+ years
Phase:
PHASE1
Brief Summary
Globally, Scabies infects 300m people each year. In children of developing countries, its prevalence is expected to be about 5 to 10%.In Pakistan, Scabies accounts for 38% of dermatological diseases. ...
Detailed Description
A randomized controlled trial study (single-blind) was done In the Dermatology Unit of the CMH, Abbottabad from June to November 2021 after Ethical Review Board approval, the 100 patients aged 5-80 ye...
Eligibility Criteria
Inclusion
- More than 2 years
- More than 15kg of body weight
- attended the Dermatology department
Exclusion
- Patients under the age of two years
- pregnant
- breastfeeding women
- those with a background of seizures, severe symptoms of systemic illnesses,
- immunosuppression diseases,
- Norwegian scabies
- those who had taken any topical or systemic acaricide medication for one month before the trial
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05362513
Start Date
June 1 2021
End Date
November 30 2021
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Combined military hospital
Abbottābād, Kpk, Pakistan